2019 annual financial data
ALX Oncology Holdings 2019 Operating margin
Direct answer
Operating margin was -399.98%.
Operating income was -19,183,000 USD and net income was -19,243,000 USD.
Operating cash flow was -14,249,000 USD.
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,796,000 USD
- Operating income
- -19,183,000 USD
- Net income
- -19,243,000 USD
- Operating cash flow
- -14,249,000 USD